ZAG | S&W

News

ZAG-S&W represents Therapix Biosciences in $13.8 Million Initial Public Offering

02.04.2017
The Firm continues to lead in the International rankings The Legal 500 EMEA in areas: Hi-Tech, Capital Markets,Trade and M&A

24.04.2017
Dun's 100 - 2017 edition has ranked ZAG-S&W among the leading law firms in Israel

24.04.2017
ZAG- S&W continues to be ranked and reccommended by IFLR 2017 as one of the leading law firms

24.04.2017
ZAG-S&W are sponsoring the MIND the TECH NY Conference of Calcalist

30.04.2017
IVC research center and ZAG-S&W report reveals that during the first quarter of 2017 investments in young start- ups have been growing

26.04.2017
Attorney Eyal Feivel of the firm delivered a speech at a joint conference of the Sports Committee of the Bureau and the organizers of the 20th Maccabiah

07.05.2017
Mind the Tech Conference - New York May 16-18

16.05.2017

Transactions and IPOs

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

IVC research center and ZAG-S&W report reveals that during the first quarter of 2017 investments in young start- ups have been growing

IVC research center and ZAG-S&W report reveals that during the first quarter of 2017 investments in young start- ups have been growing